immunization

(redirected from Active immunization)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
See: tolerance
References in periodicals archive ?
The endocrine effects of active immunization against GnRH have been studied in a variety of young adult male and female animals (15-17).
The high prevalence of HBV infection and relative failure of active immunization in patients with leukemia on therapy have prompted a search for alternative forms of prophylaxis (3).
Intercell's novel JE vaccine is a purified, inactivated vaccine for active immunization against the Japanese Encephalitis virus.
The company has a broad proprietary immunotherapy platform for both passive and active immunization against Alzheimer's disease.
et al, observed that a greater number of children born from immunized mothers presented protective levels of antibodies to PRP, without interference with the active immunization, when compared to children born from nonimmunized mothers during pregnancy [8].
This is "wonderful evidence" that the vaccine did what it was intended to do--remove A[beta] plaques via active immunization.
Decline of Haemophilus influenzae type b disease in a region of high risk; impact of passive and active immunization.
Garg studied the effect of passive and active immunization with pili of Escherichia coli in the prevention of ascending pyelonephritis.
NYSE: PFE) announced today that the European Commission has approved expanding the use of the company's pneumococcal conjugate vaccine, Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), to older children and adolescents aged 6 to 17 years for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by vaccine-type Streptococcus pneumoniae.
ACAM2000 is the only FDA-licensed vaccine for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
Trumenba was first introduced in the United States in October 2014 for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
What this means is that conventional active immunization strategies that zero in on a single target are unlikely to be successful in the case of S.